<DOC>
	<DOCNO>NCT01110330</DOCNO>
	<brief_summary>The purpose study determine new formulation ketoconazole 2 % cream effective current formulation ketoconazole 2 % cream ( Nizoral ) compare placebo treat patient Tinea pedis , skin infection commonly know `` athlete 's foot '' cause kind mold call fungus .</brief_summary>
	<brief_title>An Efficacy Study New Formulation Ketoconazole 2 % Cream Patients With Tinea Pedis , Commonly Known Athlete 's Foot</brief_title>
	<detailed_description>This randomize ( study drug assign chance ) , double-blind ( neither physician patient know name assign treatment ) , multicentre study Poland United Kingdom design assess mycological ( fungal ) cure rate clinical efficacy new formulation ketoconazole 2 % cream ( F126 ) current formulation ketoconazole 2 % cream ( Nizoral ) ( F012 ) compare placebo cream patient symptomatic uncomplicated interdigital ( toe ) Tinea pedis , skin infection commonly know `` athlete 's foot '' cause kind mold call fungus . Approximately 548 patient symptomatic uncomplicated interdigital Tinea pedis confirm positive potassium hydroxide ( KOH ) microscopy ( examination use microscope ) mycological ( fungal ) culture randomize receive 1 2 formulation ketoconazole 2 % cream ( formulation F012 F126 ) placebo cream . There 4 study visit study . At Visit 1 ( baseline ) , patient sign inform consent assess mycological clinical sign symptom Tinea pedis . Baseline demographic ( age , race , etc ) , medical history medication ( ) patient currently take record . Patients issue tube cream instruct apply cream sparingly affected area foot ( foot ) , daily ( night evening ) total 4 week accord protocol-specified guideline . During 4-week treatment period patient return study every 2 week assess clinical sign symptom . After 4-week treatment period , patient continue participation study additional 2 week without medication . Patients return return study center final visit ( Visit 4 , Week 6 ) time skin scraping sample interdigital space foot KOH microscopy mycological culture . The primary efficacy endpoint determine whether new formulation ketoconazole 2 % cream equivalent ( effective ) current formulation ketoconazole 2 % cream ( Nizoral ) compare placebo cream achieve mycological cure ( define negative KOH microscopy negative mycological culture ) follow 4 week treatment . The primary outcome measure study mycological cure ( define negative KOH microscopy negative mycological culture ) week 6 . Patients monitor safety ( occurrence adverse event , use concomitant medication , reason premature discontinuation study ) Visit 1 Visit 4 ( Week 6 time early termination study ) . Patients provide two 15g tube ketoconazole cream ( formulation F126 F012 ) match placebo cream instruct apply cream sparingly affect area foot daily night even 4 week accord protocol specify guideline .</detailed_description>
	<mesh_term>Tinea</mesh_term>
	<mesh_term>Tinea Pedis</mesh_term>
	<mesh_term>Ketoconazole</mesh_term>
	<criteria>Be cooperative , reliable sufficiently competent grade record symptom request clinical diagnosis uncomplicated interdigital Tinea pedis confirm KOH microscopy Be either postmenopausal surgically sterile , abstinent , , sexually active , practice effective method birth control entry throughout study negative urine pregnancy test screening ( applies woman ) Sign informed consent form indicate understand purpose procedure require study willingness participate study Have complicate Tinea pedis define confluent , diffuse moccasin type tinea pedis entire plantar surface ( undersurface foot ) , onychomycosis ( fungal nail infection ) dermatomycosis ( fungal skin infection ) require active treatment Have previous sensitivity imidazole antifungal agent ingredient study medication Have history disallow therapy include oral ( mouth ) antifungal treatment within previous 6 week , recent use ( within 2 week study start ) topical antifungal agent , immunosuppressive radiation therapy within previous 4 week , recent use ( within 2 week prior screen ) oral antibiotic , systemic corticosteroid topical corticosteroid antibiotic apply foot Be HIVpositive ( test perform ) Have uncontrolled diabetes mellitus peripheral vascular disease require active treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Tinea Pedis</keyword>
	<keyword>Ketoconazole ( NIZORAL )</keyword>
	<keyword>Antifungal Agents</keyword>
	<keyword>Miconazole ( DAKTARIN )</keyword>
</DOC>